NYSE ARCA | ETF
In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy.
It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index.
The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 2.05% |
| TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.99% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 1.92% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.88% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 1.84% |
| APLS | Apellis Pharmaceuticals Inc | Healthcare | Biotechnology | 1.82% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.74% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.49% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 1.49% |
| MTSR | Metsera, Inc. Common Stock | Healthcare | Biotechnology | 1.48% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 1.47% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.46% |
| NUVL | Nuvalent Inc | Healthcare | Biotechnology | 1.43% |
| APGE | Apogee Therapeutics, Inc. Common Stock | Healthcare | Biotechnology | 1.39% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 1.38% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 1.36% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.32% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 1.32% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 1.32% |
| BEAM | Beam Therapeutics Inc | Healthcare | Biotechnology | 1.31% |